Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Methamphetamine Use Disorder: early-phase trial registry
8 of 13 indexed Methamphetamine Use Disorder trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,315 of 28,707 conditions by registered trial count.
13 US clinical trials · 8 currently recruiting · #1,315 of 28,707 conditions by registered trial count
Methamphetamine Use Disorder: 13 US clinical trials tracked, 8 recruiting.
Methamphetamine Use Disorder is the subject of 13 registered US clinical trials on ClinicalTrials.gov, 8 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 8 in Phase 1-2 (earlier-stage). The most active sponsor is William Stoops, running 2 of these trials.
Enrollment posture brief
Registry condition methamphetamine-use-disorder
OPEN 8 | RECR 62% | LATE 0 | EARLY 8 | RANK #1315 | SPON 2
Volume-matched condition peers
Nearest open-share peer: High Risk Myelodysplastic Syndrome (62% recruiting · 13 trials)
Methamphetamine Use Disorder lists 8 open slots (62% of 13 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Methamphetamine Use Disorder on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Methamphetamine Use Disorder is recruiting above its size-band peers.
8 of 13 indexed trials (61.5%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Methamphetamine Use Disorder research.
William Stoops accounts for 2 of 13 trials (15.4%). 11 distinct sponsors appear on at least one study for this condition label.
-
Most Methamphetamine Use Disorder trials plan to enrol fewer than 100 people.
Median target enrolment is 20 among the 13 trials that report a genuine target (sentinel values excluded). 12 of those (92.3%) plan for fewer than 100 participants.
-
Methamphetamine Use Disorder research is mostly interventional.
12 interventional and 1 observational studies make up this index (92.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
13 total, page 1 of 1
Non-Abstinence Outcomes in Methamphetamine Use Disorder
William Stoops
NCT07226596
Methamphetamine Cue-reactivity
Icahn School of Medicine at Mount Sinai
NCT07086014
Methamphetamine and Troriluzole
William Stoops
NCT06989853
Deep TMS of Neural Circuits Associated With Stimulant Use Disorder
Stanford University
NCT06578429
Testing an Accelerated TMS Protocol for Methamphetamine Use Disorder
University of Colorado, Denver
NCT06320366
Psilocybin for Methamphetamine Addiction
Kevin Murnane
NCT06899594
A Pilot Study of Transcranial Magnetic Stimulation Plus Episodic Future Thinking for Methamphetamine Use Disorder
The University of Texas Health Science Center, Houston
NCT06712446
Ketamine-Assisted Recovery for Methamphetamine Use Disorder & HIV
Nicky Mehtani, MD, MPH
NCT06538285
Tirzepatide for Obesity and Meth Use Disorder
University of Texas Southwestern Medical Center
NCT06745128
Study of the Safety and Feasibility of Psilocybin in Adults With Methamphetamine Use Disorder
University of Wisconsin, Madison
NCT05322954
Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder
University of Colorado, Denver
NCT05558358
Intermittent Oral Naltrexone Enhanced With an Ecological Momentary Intervention for Methamphetamine-using MSM
Glenn-Milo Santos
NCT04791969
Mirtazapine and Methamphetamine Drug-drug Interaction Study
San Francisco Department of Public Health
NCT04614584
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 5 |
| Phase 2 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Methamphetamine Use Disorder records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Methamphetamine Use Disorder trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Methamphetamine Use Disorder page
13 registered trials, 8 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 8 Methamphetamine Use Disorder trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- William Stoops sponsors the most Methamphetamine Use Disorder trials on record, review their full trial history before evaluating a specific study. See William Stoops's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Methamphetamine Use Disorder condition card totals 13 registered trials; most-linked intervention Methamphetamine; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.